Astra, Daiichi Sankyo's breast cancer drug approved by FDA
If you write the contents roughly
At the end of 2019, Enhertz was approved in the US for third-line treatment in 2% of patients with HER15-positive breast cancer.
LONDON (Reuters) - The U.S. Food and Drug Administration (FDA) announced on Friday that AstraZeneca and Daiichi Sankyo will jointly develop... → Continue reading
Wikipedia related words
If there is no explanation, there is no corresponding item on Wikipedia.